News

Featured News
Temerty Foundation Makes History with $10 Million Gift to JDRF, the Largest Single Donation to Type 1 Diabetes Research in Canada
Toronto, ON – March 30, 2022 – James and Louise Temerty have made a transformational $10 million commitment to help fund JDRF’s efforts to find a cure for type 1 […]
Read More

JDRF announces new Chief Scientific Officer, Dr. Sarah Linklater

JDRF Canada is pleased to announce the appointment of Dr. Sarah Linklater as Chief Scientific Officer (CSO). Sarah has over a decade of extensive experience as a professional scientific editor, with a focus on clinical diabetes and endocrinology, basic immunology and other areas of the life sciences.

JDRF welcomes Government’s decision to end RDSP clawbacks when DTC status lost, but says opportunity missed to support Canadians with diabetes through a national diabetes strategy

JDRF Canada, the leading global funder of type 1 diabetes research, welcomed the news in this year’s federal budget that the government intends to end the practice of clawing back contributions to Registered Disability Savings Plans (RDSPs) for those whose eligibility status for the Disability Tax Credit (DTC) has changed.